These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

302 related articles for article (PubMed ID: 4026905)

  • 21. Pharmacokinetics, protein binding and metabolic profile of 3H-icometasone enbutate following intravenous, oral and intratracheal administrations to Sprague-Dawley rats.
    Duchêne P; Giudicelli MD; Neau B; Gronfier A; Firmin Y; Villax P; Saivin S; Houin G
    Arzneimittelforschung; 1998 Apr; 48(4):371-8. PubMed ID: 9608879
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Absorption, distribution and excretion of 2,4-diamino-6-(2,5-dichlorophenyl)-s-triazine maleate in rats, dogs and monkeys.
    Ando T; Momota K; Sugiyama M
    Arzneimittelforschung; 1986 Aug; 36(8):1221-8. PubMed ID: 3778559
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Disposition and metabolism of amosulalol hydrochloride, a new combined alpha- and beta-adrenoceptor blocking agent, in rats, dogs and monkeys.
    Sasaki H; Kamimura H; Kaniwa H; Kawamura S; Takaichi M; Yokoshima T
    Xenobiotica; 1984 Aug; 14(8):621-31. PubMed ID: 6149657
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pharmacokinetics, tissue distribution, metabolism, and excretion of celecoxib in rats.
    Paulson SK; Zhang JY; Breau AP; Hribar JD; Liu NW; Jessen SM; Lawal YM; Cogburn JN; Gresk CJ; Markos CS; Maziasz TJ; Schoenhard GL; Burton EG
    Drug Metab Dispos; 2000 May; 28(5):514-21. PubMed ID: 10772629
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Metabolic fate of the new Ca++-channel blocking agent (+)-(2S,3S)-3-acetoxy-8-chloro-(2-(dimethylamino)ethyl)-2,3-dihydro- 2-(4-methoxyphenyl)-2,5-benzothiazepin-4-(5H)-one maleate. Distribution, excretion and protein binding in rats and dogs.
    Nakamura S; Ohashi M; Suzuki T; Sugawara Y; Usuki S; Takaiti O
    Arzneimittelforschung; 1989 Sep; 39(9):1100-8. PubMed ID: 2590259
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pharmacokinetics of NS-49, a phenethylamine class alpha 1A-adrenoceptor agonist. 1st communication: absorption and excretion in rats after a single administration of 14C-NS-49.
    Mukai H; Watanabe S; Morino A
    Arzneimittelforschung; 1999 May; 49(5):434-40. PubMed ID: 10367106
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmacokinetics of NS-105, a novel cognition enhancer. 2nd communication: distribution and transfer into fetus and milk after single administration, and effects of repeated administration on pharmacokinetics and hepatic drug-metabolizing enzyme activities in rats.
    Mukai H; Sugimoto T; Ago M; Morino A; Takaichi M; Ogawa Y; Seki H; Matsuura C; Esumi Y
    Arzneimittelforschung; 1999 Dec; 49(12):977-85. PubMed ID: 10635441
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Absorption, distribution, metabolism and excretion of YM466, a novel factor Xa inhibitor, in rats.
    Mano Y; Sonoda T; Nakamura E; Usui T; Kamimura H
    Biopharm Drug Dispos; 2004 Sep; 25(6):253-60. PubMed ID: 15334624
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Metabolic fate of the new cardiotonic denopamine in animals. 1st communication: absorption, distribution and excretion in the rat, rabbit and dog.
    Naito K; Furuuchi S; Yamada Y; Otsuka M; Harigaya S
    Arzneimittelforschung; 1986 Apr; 36(4):643-51. PubMed ID: 3718588
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pharmacokinetics of nimodipine. I. Communication: absorption, concentration in plasma and excretion after single administration of [14C]nimodipine in rat, dog and monkey.
    Maruhn D; Siefert HM; Weber H; Rämsch K; Suwelack D
    Arzneimittelforschung; 1985; 35(12):1781-6. PubMed ID: 4096729
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Absorption, distribution, metabolism, and excretion of donepezil (Aricept) after a single oral administration to Rat.
    Matsui K; Mishima M; Nagai Y; Yuzuriha T; Yoshimura T
    Drug Metab Dispos; 1999 Dec; 27(12):1406-14. PubMed ID: 10570021
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pharmacokinetics of nisoldipine. III. Biotransformation of nisoldipine in rat, dog, monkey, and man.
    Scherling D; Karl W; Ahr G; Ahr HJ; Wehinger E
    Arzneimittelforschung; 1988 Aug; 38(8):1105-10. PubMed ID: 2973788
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Metabolism and disposition of moxonidine in Fischer 344 rats.
    He MM; Abraham TL; Lindsay TJ; Chay SH; Czeskis BA; Shipley LA
    Drug Metab Dispos; 2000 Apr; 28(4):446-59. PubMed ID: 10725314
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pharmacokinetics of nisoldipine. II. Distribution to and elimination from tissues and organs following single or repeated administration of [14C]nisoldipine to rats and dogs.
    Ahr HJ; Krause HP; Suwelack D; Weber H
    Arzneimittelforschung; 1988 Aug; 38(8):1099-104. PubMed ID: 3196403
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Disposition and metabolism of [14C]-amezinium metilsulfate in rats.
    Nambu K; Yoshida K; Kagemoto A; Matsumoto K; Miyazaki H; Hashimoto M; Esumi Y; Jin Y; Gunji S; Iwabuchi M
    Arzneimittelforschung; 1988 Jul; 38(7):909-18. PubMed ID: 3207436
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pharmacokinetics and metabolism of the new thromboxane A2 receptor antagonist ramatroban in animals. 1st communication: absorption, concentrations in plasma, metabolism, and excretion after single administration to rats and dogs.
    Boberg M; Ahr HJ; Beckermann B; Bühner K; Siefert HM; Steinke W; Wünsche C; Hirayama M
    Arzneimittelforschung; 1997 Aug; 47(8):928-38. PubMed ID: 9296279
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Acute and subacute toxicity of 2,6-dimethyl-3,5-dimethoxycarbonyl-4-(o-difluoromethoxyphenyl)-1 ,4-dihydropyridine (PP-1466).
    Gomi T; Yamamoto H; Ozeki M; Fujikura M; Hirao A; Kobayashi M; Tateishi T; Yumoto S; Okumura M; Aikawa K
    Arzneimittelforschung; 1985; 35(6):915-22. PubMed ID: 4026916
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmacokinetics of prulifloxacin. 2nd communication: pharmacokinetics and effect on hepatic drug-metabolizing enzyme activities after repeated administration and transfer into fetus and milk after a single administration in rats.
    Okuyama Y; Momota K; Morino A
    Arzneimittelforschung; 1997 Mar; 47(3):285-92. PubMed ID: 9105547
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Disposition and metabolism of [14C]sparfloxacin in the rat.
    Matsunaga Y; Miyazaki H; Oh-e Y; Nambu K; Furukawa H; Yoshida K; Hashimoto M
    Arzneimittelforschung; 1991 Jul; 41(7):747-59. PubMed ID: 1663354
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Absorption, distribution and excretion of 14C-pirenzepine in rats. Accumulation characteristics after multiple dose regimen.
    Kobayashi S; Kyui S; Yoshida T; Nagakura A; Oiwa Y; Matsumura R; Kohei H
    Arzneimittelforschung; 1981; 31(4):679-90. PubMed ID: 6894697
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.